Royal Bank of Canada’s Performant Healthcare Inc PHLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,582
| Closed | -$12K | – | 7788 |
|
|
2025
Q3 | $12K | Sell |
1,582
-34,685
| -96% | -$221K | ﹤0.01% | 6436 |
|
|
2025
Q2 | $146K | Buy |
36,267
+34,941
| +2,635% | +$99.1K | ﹤0.01% | 5380 |
|
|
2025
Q1 | $4K | Sell |
1,326
-112
| -8% | -$290 | ﹤0.01% | 6453 |
|
|
2024
Q4 | $5K | Sell |
1,438
-7,520
| -84% | -$25.8K | ﹤0.01% | 6561 |
|
|
2024
Q3 | $33K | Buy |
8,958
+1,736
| +24% | +$5.93K | ﹤0.01% | 5882 |
|
|
2024
Q2 | $21K | Buy |
7,222
+4,192
| +138% | +$12K | ﹤0.01% | 6067 |
|
|
2024
Q1 | $10K | Sell |
3,030
-18,744
| -86% | -$53.6K | ﹤0.01% | 6220 |
|
|
2023
Q4 | $68K | Buy |
21,774
+12,043
| +124% | +$31.6K | ﹤0.01% | 5841 |
|
|
2023
Q3 | $22K | Buy |
9,731
+4,009
| +70% | +$10.2K | ﹤0.01% | 6153 |
|
|
2023
Q2 | $16K | Buy |
5,722
+5,112
| +838% | +$14.8K | ﹤0.01% | 6319 |
|
|
2023
Q1 | $2K | Hold |
610
| – | – | ﹤0.01% | 6815 |
|
|
2022
Q4 | $2K | Sell |
610
-121
| -17% | -$283 | ﹤0.01% | 6960 |
|
|
2022
Q3 | $1K | Buy |
731
+121
| +20% | +$281 | ﹤0.01% | 7307 |
|
|
2022
Q2 | $2K | Hold |
610
| – | – | ﹤0.01% | 7014 |
|
|
2022
Q1 | $2K | Buy |
610
+249
| +69% | +$586 | ﹤0.01% | 7516 |
|
|
2021
Q4 | $1K | Buy |
+361
| New | +$1.07K | ﹤0.01% | 7557 |
|
|
2020
Q4 | – | Sell |
-1
| Closed | – | – | 7338 |
|
|
2020
Q3 | $0 | Sell |
1
-1,079
| -100% | -$696 | ﹤0.01% | 6989 |
|
|
2020
Q2 | $1K | Buy |
1,080
+132
| +14% | +$91 | ﹤0.01% | 6499 |
|
|
2020
Q1 | $1K | Buy |
948
+454
| +92% | +$466 | ﹤0.01% | 6508 |
|
|
2019
Q4 | $1K | Sell |
494
-83
| -14% | -$80 | ﹤0.01% | 6701 |
|
|
2019
Q3 | $1K | Buy |
+577
| New | +$679 | ﹤0.01% | 6533 |
|
|
2018
Q4 | – | Sell |
-89
| Closed | – | – | 7184 |
|
|
2018
Q3 | $0 | Buy |
89
+88
| +8,800% | +$185 | ﹤0.01% | 6995 |
|
|
2018
Q2 | $0 | Buy |
+1
| New | +$3 | ﹤0.01% | 6822 |
|
|
2018
Q1 | – | Sell |
-8
| Closed | – | – | 6868 |
|
|
2017
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 6957 |
|
|
2017
Q3 | $0 | Buy |
+8
| New | +$15 | ﹤0.01% | 7036 |
|
|
2016
Q3 | – | Sell |
-1,167
| Closed | -$2K | – | 6610 |
|
|
2016
Q2 | $2K | Sell |
1,167
-599
| -34% | -$1.02K | ﹤0.01% | 6167 |
|
|
2016
Q1 | $3K | Buy |
+1,766
| New | +$3.06K | ﹤0.01% | 6063 |
|
|
2015
Q4 | – | Sell |
-490
| Closed | -$1K | – | 6847 |
|
|
2015
Q3 | $1K | Buy |
490
+435
| +791% | +$1.26K | ﹤0.01% | 6523 |
|
|
2015
Q2 | $0 | Sell |
55
-14,833
| -100% | -$46.1K | ﹤0.01% | 6750 |
|
|
2015
Q1 | $51K | Sell |
14,888
-155,519
| -91% | -$789K | ﹤0.01% | 4959 |
|
|
2014
Q4 | $1.13M | Buy |
170,407
+14,174
| +9% | +$104K | ﹤0.01% | 2819 |
|
|
2014
Q3 | $1.26M | Sell |
156,233
-8,000
| -5% | -$77K | ﹤0.01% | 2663 |
|
|
2014
Q2 | $1.66M | Hold |
164,233
| – | – | ﹤0.01% | 2431 |
|
|
2014
Q1 | $1.49M | Buy |
164,233
+1,104
| +0.7% | +$9.59K | ﹤0.01% | 2467 |
|
|
2013
Q4 | $1.68M | Buy |
163,129
+27,796
| +21% | +$280K | ﹤0.01% | 2423 |
|
|
2013
Q3 | $1.48M | Buy |
+135,333
| New | +$1.48M | ﹤0.01% | 2431 |
|
Other funds holding PHLT
Royal Bank of Canada's PHLT Position: Q4 2025 in Review
Royal Bank of Canada sold out of Performant Healthcare Inc (PHLT) in Q4 2025, closing a stake of 1,582 shares — an estimated $12K sold.
Royal Bank of Canada first reported a position in PHLT in Q3 2013 and held it in 36 quarters. The position peaked at $1.68M in Q4 2013. 1 fund tracked by Wall St. Rank holds PHLT as of Q4 2025.
- Royal Bank of Canada reported no remaining Performant Healthcare Inc position as of Q4 2025 after selling out during the quarter.
- Royal Bank of Canada sold 1,582 Performant Healthcare Inc shares in Q4 2025, an estimated $12K.
- Royal Bank of Canada first reported a position in Performant Healthcare Inc in Q3 2013 and held it in 36 quarters.
- Royal Bank of Canada's Performant Healthcare Inc position peaked at $1.68M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Performant Healthcare Inc as of Q4 2025.
Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.